Discover opportunities for flexible automation with this technology demonstration from Sean Werner, President of Sexton Biotechnologies, as featured during the latest Phacilitate Automation SIG (June 2021)
PLAY VIDEO ABOVE * Sexton Biotechnologies, the sponsor of this content would like to send you information about their products and services. If you do not wish to receive these emails, click here to opt out.
“Our belief when we introduced the Signata platform and the Signata-CT5 was that flexibility and the ability to integrate between unit operations was really key for advancing cell therapy manufacturing…”
In this demonstration video, Sean explains how it is possible to semi-automate your cell manufacturing process, bringing your process even closer to a true GMP protocol.
Watch as Sean walks through connecting outputs to the Signata system, including connecting Sexton’s proprietary vials or bags as well as connecting the system to bioreactors or other growth chambers.
The demonstration closes with a short Q&A, including questions:
- What makes this fill and finish system better than alternatives currently on the market? [19:18]
- How will this platform maintain relevancy as the cell and gene therapy industry continues to grow? [20:24]